Literature DB >> 27392313

Human Umbilical Cord Wharton's Jelly Stem Cell Conditioned Medium Induces Tumoricidal Effects on Lymphoma Cells Through Hydrogen Peroxide Mediation.

Hao Daniel Lin1, Chui-Yee Fong1, Arijit Biswas1, Mahesh Choolani1, Ariff Bongso1.   

Abstract

Several groups have reported that human umbilical cord Wharton's jelly stem cells (hWJSCs) possess unique tumoricidal properties against many cancers. However, the exact mechanisms as to how hWJSCs inhibit tumor growth are not known. Recent evidence suggests that exposure of cancer cells to high hydrogen peroxide (H2 O2 ) levels from H2 O2 -releasing drugs causes their death. We therefore explored whether the tumoricidal effect of hWJSCs on lymphoma cells was mediated via H2 O2 . We first exposed lymphoma cells to six different molecular weight cut-off (MWCO) concentrates of hWJSC-conditioned medium (hWJSC-CM) (3, 5, 10, 30, 50, 100 kDa) for 48 h. Since, the 3 kDa-MWCO concentrate showed the greatest cell inhibition we then investigated whether the tumoricidal effect of the specific 3 kDa-MWCO concentrate on two different lymphoma cell lines (Ramos and Toledo) was mediated via accumulation of H2 O2 . We used a battery of assays (MTT, propidium iodide, mitochondria membrane potential, apoptosis, cell cycle, oxidative stress enzymes, hydrogen peroxide, mitochondrial superoxide, hydroxyl radical, peroxynitrile anion, and lipid peroxidation) to test this mechanism. The hWJSC-CM-3 kDa MWCO concentrate significantly decreased cell viability and mitochondrial membrane potential and increased cell death and apoptosis in both lymphoma cell lines. There were significant increases in superoxide dismutase with concomitant decreases in glutathione peroxidase, catalase, and thioredoxin peroxidase activities. H2 O2 levels, mitochondrial superoxide, hydroxyl radical, peroxynitrile anion, and lipid peroxidation were also significantly increased in both lymphoma cell lines. The results suggested that the hWJSC-CM-3 kDa MWCO concentrate regulates cellular H2 O2 leading to a tumoricidal effect and may thus be a promising anti-lymphoma agent. J. Cell. Biochem. 117: 2045-2055, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  CANCER CELL INHIBITION; CONDITIONED MEDIUM; H2O2 SIGNALING; HUMAN WHARTON'S JELLY STEM CELLS; LYMPHOMA; OXIDATIVE STRESS; OXIDATIVE STRESS ENZYMES

Mesh:

Substances:

Year:  2016        PMID: 27392313     DOI: 10.1002/jcb.25501

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

1.  Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review.

Authors:  Ioannis Christodoulou; Maria Goulielmaki; Marina Devetzi; Mihalis Panagiotidis; Georgios Koliakos; Vassilis Zoumpourlis
Journal:  Stem Cell Res Ther       Date:  2018-12-07       Impact factor: 6.832

2.  Mesenchymal Stem Cells Inhibit the Effects of Dexamethasone in Multiple Myeloma Cells.

Authors:  Mingyang Deng; Huan Yuan; Hongling Peng; Sufang Liu; Xiang Xiao; Zhihua Wang; Guangsen Zhang; Han Xiao
Journal:  Stem Cells Int       Date:  2022-04-04       Impact factor: 5.443

3.  Conditioned Medium of Wharton's Jelly Derived Stem Cells Can Enhance the Cartilage Specific Genes Expression by Chondrocytes in Monolayer and Mass Culture Systems.

Authors:  Maryam Hassan Famian; Soheila Montazer Saheb; Azadeh Montaseri
Journal:  Adv Pharm Bull       Date:  2017-04-13

Review 4.  A Bird's-Eye View of Cell Sources for Cell-Based Therapies in Blood Cancers.

Authors:  Benjamin Motais; Sandra Charvátová; Matouš Hrdinka; Michal Šimíček; Tomáš Jelínek; Tereza Ševčíková; Zdeněk Kořístek; Roman Hájek; Juli R Bagó
Journal:  Cancers (Basel)       Date:  2020-05-23       Impact factor: 6.639

Review 5.  Mesenchymal stem cells in acute myeloid leukemia: a focus on mechanisms involved and therapeutic concepts.

Authors:  Ezzatollah Fathi; Zohreh Sanaat; Raheleh Farahzadi
Journal:  Blood Res       Date:  2019-09-25

Review 6.  Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications.

Authors:  Wei-Zhan Zhuang; Yi-Heng Lin; Long-Jyun Su; Meng-Shiue Wu; Han-Yin Jeng; Huan-Cheng Chang; Yen-Hua Huang; Thai-Yen Ling
Journal:  J Biomed Sci       Date:  2021-04-14       Impact factor: 8.410

7.  Mesenchymal stem cells promote caspase-3 expression of SH-SY5Y neuroblastoma cells via reducing telomerase activity and telomere length.

Authors:  Ezzatollah Fathi; Somayeh Vandghanooni; Soheila Montazersaheb; Raheleh Farahzadi
Journal:  Iran J Basic Med Sci       Date:  2021-11       Impact factor: 2.699

Review 8.  Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges.

Authors:  Myoung Woo Lee; Somi Ryu; Dae Seong Kim; Ji Won Lee; Ki Woong Sung; Hong Hoe Koo; Keon Hee Yoo
Journal:  Leukemia       Date:  2019-01-31       Impact factor: 11.528

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.